VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $651,000 | +70.9% | 58,983 | +125.0% | 0.01% | +150.0% |
| Q4 2016 | $381,000 | -3.5% | 26,216 | +1083.6% | 0.00% | 0.0% |
| Q3 2015 | $395,000 | +23.1% | 2,215 | +53.2% | 0.00% | +100.0% |
| Q2 2015 | $321,000 | -87.5% | 1,446 | -92.6% | 0.00% | -90.9% |
| Q1 2014 | $2,569,000 | +220.7% | 19,491 | +185.6% | 0.01% | +266.7% |
| Q4 2013 | $801,000 | -17.2% | 6,825 | -26.3% | 0.00% | 0.0% |
| Q3 2013 | $967,000 | -64.0% | 9,266 | -70.3% | 0.00% | -70.0% |
| Q2 2013 | $2,688,000 | – | 31,230 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |